Skip to main content
Sign In

University of Colorado Cancer Center

University of Colorado Cancer Center, A National Cancer Institute-designated Comprehensive Cancer Center
 

Yiqun Shellman, PhD

Preceptor


Categories:

Cell Growth, Death and Senescence, Signaling Pathways, Oncogenes and Tumor Suppressor Genes, Gene Regulation and Transcription Factors, Tumor progression, invasion and metastasis, and Experimental and Molecular Therapeutics

Specialty:

Melanoma

Location:

University of Colorado Anschutz Medical Campus, Department of Dermatology

Prerequisites: 

Must have completed three years of college

Number of Openings: 1

Objective:  To better understand the progression and resistance to therapy of melanoma, and thus to find better treatment strategy

Description:  

  1. To examine the treatment potential of combining a small molecule inhibitor of Bcl-2 family members with conventional therapeutic agents to treat melanoma cells and melanoma-stem cells.
  2. To explore the roles of miRNAs in melanoma tumorigenesis and therapeutic potential of miRNA in melanoma treatment.